Dr. Richard Wright and Dr. C. Michael Gibson discuss: Transthyretin tetramer destabilization and increased mortality, and the physiologic importance of TTR.
Disclosures: Sponsored by BridgeBio Pharma, Inc
Clinical Trial Results
Disclosures: Sponsored by BridgeBio Pharma, Inc
Disclosures: Sponsored by BridgeBio Pharma, Inc.
Disclosures: Sponsored by BridgeBio Pharma, Inc.
Participants randomized to the placebo arm in obesity trials often do not lose weight and as a result may drop out […]
Dr. Javed Butler and Dr. C. Michael Gibson discuss the flaws of BMI in obesity trials
Dr. Shinya Goto and I discuss the vexing problem of antiplatelet and anticoagulant therapy in patients with hereditary clotting disorders like hemophilia.
Dr. Javed Butler and I discuss the flaws of BMI in obesity trials
While Lp(a) was associated with Major Adverse Cardiovascular Events (MACE), it was not independently associated with all cause or CV […]
Dr. Merhran and I discuss the HOST-BR trial (optimal DAPT duration for high or low bleeding risk), ECLIPSE trial (orbital […]